| Year |
Citation |
Score |
| 2022 |
Whitehouse PJ, George DR. Dignity for All: How the Challenges of Alzheimer's Disease Need Rethinking and Revaluing. Journal of Alzheimer's Disease : Jad. PMID 36404553 DOI: 10.3233/JAD-221066 |
0.364 |
|
| 2022 |
Whitehouse P, Gandy S, Saini V, George DR, Larson EB, Alexander GC, Avorn J, Brownlee S, Camp C, Chertkow H, Fugh-Berman A, Howard R, Kesselheim A, Langa K, Perry G, et al. Making the Case for Accelerated Withdrawal of Aducanumab. Journal of Alzheimer's Disease : Jad. PMID 35404287 DOI: 10.3233/JAD-220262 |
0.409 |
|
| 2022 |
George DR, Whitehouse PJ. How Not to Study a Disease: The Story of Alzheimer's by Karl Herrup, The MIT Press, 2021, 245 pp. Journal of Alzheimer's Disease : Jad. PMID 35124655 DOI: 10.3233/JAD-220035 |
0.362 |
|
| 2017 |
Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 28726810 DOI: 10.1038/Gim.2017.103 |
0.326 |
|
| 2016 |
George DR, Whitehouse ER, Whitehouse PJ. Asking More of Our Metaphors: Narrative Strategies to End the "War on Alzheimer's" and Humanize Cognitive Aging. The American Journal of Bioethics : Ajob. 16: 22-4. PMID 27653394 DOI: 10.1080/15265161.2016.1214307 |
0.355 |
|
| 2016 |
George DR, Whitehouse PJ. Review of The Alzheimer's Conundrum by Margaret Lock. Culture, Medicine and Psychiatry. PMID 27075567 DOI: 10.1007/S11013-016-9492-9 |
0.383 |
|
| 2016 |
Christensen KD, Roberts JS, Whitehouse PJ, Royal CD, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye GA, Uhlmann WR, Hiraki S, Wang N, Cook-Deegan R, et al. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized, Controlled Trial. Annals of Internal Medicine. PMID 26810768 DOI: 10.7326/M15-0187 |
0.316 |
|
| 2016 |
Whitehouse PJ, Lock M. P4-248: Monster in the Mind: A New Research Documentary on Alzheimer's Alzheimer's & Dementia. 12: P1125-P1126. DOI: 10.1016/J.Jalz.2016.06.2340 |
0.343 |
|
| 2015 |
Whitehouse PJ, George DR. A Tale of Two Reports: What Recent Publications from the Alzheimer's Association and Institute of Medicine say about the State of the Field. Journal of Alzheimer's Disease : Jad. 49: 21-5. PMID 26444797 DOI: 10.3233/Jad-150663 |
0.322 |
|
| 2015 |
Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz W, Wang Y, Whitehouse P, Lerner A. From Neurodegeneration to Brain Health: An Integrated Approach. Journal of Alzheimer's Disease : Jad. PMID 25720413 DOI: 10.3233/Jad-150043 |
0.449 |
|
| 2014 |
Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CD, Obisesan TO, Cook-Deegan R, Linnenbringer E, Butson MB, Fasaye G, Levinson E, Roberts JS. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25499536 DOI: 10.1016/J.Jalz.2014.10.014 |
0.403 |
|
| 2014 |
D'Alton S, Hunter S, Whitehouse P, Brayne C, George D. Adapting to dementia in society: a challenge for our lifetimes and a charge for public health. Journal of Alzheimer's Disease : Jad. 42: 1151-63. PMID 25024316 DOI: 10.3233/Jad-140213 |
0.351 |
|
| 2014 |
Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Galasko D, Schneider LS, Aisen PS. Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. Journal of the American Geriatrics Society. 62: 985-8. PMID 24828933 DOI: 10.1111/Jgs.12816 |
0.396 |
|
| 2014 |
George DR, Whitehouse PJ. Chasing the "white whale" of Alzheimer's. Journal of the American Geriatrics Society. 62: 588-9. PMID 24628643 DOI: 10.1111/Jgs.12713 |
0.4 |
|
| 2014 |
George DR, Whitehouse PJ. The War (on Terror) on Alzheimer's. Dementia (London, England). 13: 120-30. PMID 24381043 DOI: 10.1177/1471301212451382 |
0.372 |
|
| 2014 |
Whitehouse PJ. The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective. Biochemical Pharmacology. 88: 677-81. PMID 24304687 DOI: 10.1016/J.Bcp.2013.11.017 |
0.418 |
|
| 2014 |
Roberts JS, Christensen KD, Waterston LB, Duggan J, Alerhand S, Cupples LA, Whitehouse PJ, Obisesan TO, Green RC. What Is The Long-Term Emotional And Behavioral Impact Of Genetic Risk Assessment For Alzheimer'S Disease? Findings From The Reveal Study Alzheimers & Dementia. 10: 211. DOI: 10.1016/J.Jalz.2014.04.279 |
0.327 |
|
| 2013 |
George DR, Qualls SH, Camp CJ, Whitehouse PJ. Renovating Alzheimer's: "constructive" reflections on the new clinical and research diagnostic guidelines. The Gerontologist. 53: 378-87. PMID 22936533 DOI: 10.1093/Geront/Gns096 |
0.422 |
|
| 2013 |
Whitehouse P. The Challenges of Cognitive Aging: Integrating Approaches from Neuroscience to Intergenerational Relationships Journal of Intergenerational Relationships. 11: 105-117. DOI: 10.3233/Jad-130116 |
0.321 |
|
| 2012 |
George DR, Whitehouse PJ, D'Alton S, Ballenger J. Through the amyloid gateway. Lancet. 380: 1986-7. PMID 23236607 DOI: 10.1016/S0140-6736(12)62145-X |
0.308 |
|
| 2011 |
Whitehouse PJ, George DR. Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines. Journal of Alzheimer's Disease : Jad. 26: 1-5. PMID 21743133 DOI: 10.3233/Jad-2011-111020 |
0.417 |
|
| 2011 |
George DR, Whitehouse PJ, Ballenger J. The evolving classification of dementia: placing the DSM-V in a meaningful historical and cultural context and pondering the future of "Alzheimer's". Culture, Medicine and Psychiatry. 35: 417-35. PMID 21594753 DOI: 10.1007/S11013-011-9219-X |
0.464 |
|
| 2011 |
Whitehouse PJ, George DR, D'Alton S. Describing the dying days of "Alzheimer's disease". Journal of Alzheimer's Disease : Jad. 24: 11-3. PMID 21187588 DOI: 10.3233/Jad-2010-101639 |
0.391 |
|
| 2011 |
Miyamoto M, George DR, Whitehouse PJ. Government, professional and public efforts in japan to change the designation of dementia (chihō) Dementia. 10: 475-486. DOI: 10.1177/1471301211416616 |
0.326 |
|
| 2011 |
Bradbury M, Chen C, Lautenbach D, Christensen K, Cupples L, Whitehouse P, Relkin N, Obisesan T, Roberts J, Green R. False Reassurance Following Genetic Susceptibility Testing for Alzheimer’s Disease: Evidence from the REVEAL Study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.493 |
0.303 |
|
| 2011 |
Green R, Christensen K, Uhlmann W, Whitehouse P, Obisesan T, Cupples LA, Roberts JS. P3-402: A randomized trial examining recall and distress after telephone versus in-person disclosure of genetic risk information about Alzheimer's disease: the REVEAL study Alzheimer's & Dementia. 7: S643-S644. DOI: 10.1016/J.Jalz.2011.05.1845 |
0.358 |
|
| 2010 |
Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B. B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. Journal of Alzheimer's Disease : Jad. 22: 205-24. PMID 20847412 DOI: 10.3233/Jad-2010-090940 |
0.349 |
|
| 2010 |
Vayda SE, Patterson MB, Whitehouse PJ. The future of dementia: a case of hardening of the categories. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 755-8. PMID 20808144 DOI: 10.1097/Jgp.0B013E3181Eb5A8B |
0.409 |
|
| 2010 |
Christensen K, Roberts JS, Uhlmann WR, Whitehouse PJ, Obisesan T, Bhatt DL, Green RC. O2-01-05: The psychological impact of learning about APOE-cardiovascular disease associations during genetic risk assessment for Alzheimer's disease: Findings from the reveal study Alzheimer's & Dementia. 6: S96-S96. DOI: 10.1016/J.Jalz.2010.05.302 |
0.377 |
|
| 2010 |
Whitehouse PJ. Dementia: Alzheimer's Encyclopedia of Gerontology. 374-379. DOI: 10.1016/B0-12-370870-2/00049-4 |
0.33 |
|
| 2009 |
Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nature Reviews. Neurology. 5: 649-58. PMID 19918254 DOI: 10.1038/Nrneurol.2009.175 |
0.409 |
|
| 2009 |
George DR, Dangour AD, Smith L, Ruddick J, Vellas B, Whitehouse PJ. The role of nutrients in the prevention and treatment of Alzheimer's disease: methodology for a systematic review. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 8-11. PMID 19703214 DOI: 10.1111/J.1468-1331.2009.02736.X |
0.388 |
|
| 2009 |
Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA. Disclosure of APOE genotype for risk of Alzheimer's disease. The New England Journal of Medicine. 361: 245-54. PMID 19605829 DOI: 10.1056/Nejmoa0809578 |
0.342 |
|
| 2009 |
Fotuhi M, Hachinski V, Whitehouse P. Paradigm shift from Alzheimer-centric view of brain aging and dementia: Dynamic Polygon Hypothesis Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.04.357 |
0.375 |
|
| 2008 |
Whitehouse PJ, Sami SA. Quality of life in dementias. Handbook of Clinical Neurology. 89: 97-100. PMID 18631734 DOI: 10.1016/S0072-9752(07)01208-0 |
0.34 |
|
| 2008 |
Whitehouse PJ. National Institute of Health and Clinical Excellence decision processes supported by UK High Court: the debate about the value of Alzheimer's disease drugs continues. Journal of Alzheimer's Disease : Jad. 13: 239-40. PMID 18567175 DOI: 10.3233/Jad-2008-13301 |
0.301 |
|
| 2008 |
Green RC, Roberts JS, Cupples LA, Hiraki S, Obisesan T, Relkin N, Royal C, Whitehouse P. P.5.b.003 Apolipoprotein E disclosure for genetic risk assessment of Alzheimer's disease: preparing for pharmacogenetics European Neuropsychopharmacology. 18. DOI: 10.1016/S0924-977X(08)70767-3 |
0.354 |
|
| 2008 |
Whitehouse P, George D. P1-383: Is Alzheimers disease an outmoded concept? Putting the patient and the science first Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.965 |
0.392 |
|
| 2008 |
Christensen K, Roberts JS, Royal CDM, Cupples LA, Whitehouse PJ, Relkin NR, Linnenbringer E, Butson MB, Fasaye G, Green RC. P3-488: The impact of an education and risk evaluation protocol on perceived benefits and risks of genetic susceptibility testing for Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2059 |
0.32 |
|
| 2008 |
Roberts S, Linnenbringer E, Butson MB, Whitehouse P, Fasaye G, Obisesan T, Royal C, Relkin N, Cupples LA, Chen C, Green RC. P2-282: Impact of a condensed protocol for disclosing APOE genotype to first-degree relatives of people with Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1358 |
0.412 |
|
| 2007 |
Whitehouse PJ, Waller S. Involuntary emotional expressive disorder: a case for a deeper neuroethics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 4: 560-7. PMID 17599723 DOI: 10.1016/J.Nurt.2007.03.003 |
0.357 |
|
| 2007 |
Whitehouse PJ. Commentary: integrative narrative evolutionary health: toward a wiser view of Alzheimer's disease. Journal of Alternative and Complementary Medicine (New York, N.Y.). 13: 341-4. PMID 17480133 DOI: 10.1089/Acm.2006.6404 |
0.403 |
|
| 2007 |
Whitehouse P. The next 100 years of Alzheimer's — learning to care, not cure Dementia. 6: 459-462. DOI: 10.1177/1471301207084364 |
0.303 |
|
| 2006 |
Eckert SL, Katzen H, Roberts JS, Barber M, Ravdin LD, Relkin NR, Whitehouse PJ, Green RC. Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 8: 746-51. PMID 17172937 DOI: 10.1097/01.Gim.0000250197.44245.A3 |
0.331 |
|
| 2006 |
Whitehouse PJ, Rajcan JL, Sami SA, Patterson MB, Smyth KA, Edland SD, George DR. ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy. Alzheimer Disease and Associated Disorders. 20: S203-8. PMID 17135813 DOI: 10.1097/01.Wad.0000213876.70794.C6 |
0.313 |
|
| 2006 |
Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders. 20: S191-202. PMID 17135812 DOI: 10.1097/01.Wad.0000213875.63171.87 |
0.353 |
|
| 2006 |
Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Disease and Associated Disorders. 20: S109-23. PMID 17135805 DOI: 10.1097/01.Wad.0000213870.40300.21 |
0.352 |
|
| 2006 |
Whitehouse PJ. The end of AD. Part 3. Alzheimer Disease and Associated Disorders. 20: 195-8. PMID 17132959 DOI: 10.1097/01.Wad.0000213864.02182.F7 |
0.348 |
|
| 2006 |
Whitehouse PJ. Quality of life: the bridge from the cholinergic basal forebrain to cognitive science and bioethics. Journal of Alzheimer's Disease : Jad. 9: 447-53. PMID 16914884 DOI: 10.3233/Jad-2006-9S351 |
0.449 |
|
| 2006 |
Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, ... ... Whitehouse P, et al. Mild cognitive impairment. Lancet. 367: 1262-70. PMID 16631882 DOI: 10.1016/S0140-6736(06)68542-5 |
0.359 |
|
| 2006 |
Whitehouse PJ. Demystifying the Mystery of Alzheimer's as Late, No Longer Mild Cognitive Impairment Philosophy, Psychiatry, &Amp; Psychology. 13: 87-88. DOI: 10.1353/Ppp.2006.0049 |
0.358 |
|
| 2006 |
Gaines AD, Whitehouse PJ. Building a Mystery: Alzheimer's Disease, Mild Cognitive Impairment, and Beyond Philosophy, Psychiatry, & Psychology. 13: 61-74. DOI: 10.1353/Ppp.2006.0037 |
0.439 |
|
| 2006 |
Whitehouse PJ, Moody HR. Mild cognitive impairment Dementia. 5: 11-25. DOI: 10.1177/1471301206059752 |
0.328 |
|
| 2006 |
Green RC, Roberts JS, Relkin NR, Whitehouse PJ, Royal C, Obisesan T, Erin L, Cox E, Barber M, Fasaye G. P1-273: Extended versus condensed protocol for disclosing genetic susceptibility for Alzheimer's disease: The reveal Study Alzheimer's & Dementia. 2: S176-S176. DOI: 10.1016/J.Jalz.2006.05.650 |
0.386 |
|
| 2005 |
Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. Journal of Geriatric Psychiatry and Neurology. 18: 250-5. PMID 16306249 DOI: 10.1177/0891988705281883 |
0.33 |
|
| 2005 |
Whitehouse PJ, Juengst ET. Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics. Journal of the American Geriatrics Society. 53: 1417-22. PMID 16078972 DOI: 10.1111/J.1532-5415.2005.53411.X |
0.351 |
|
| 2005 |
LaRusse S, Roberts JS, Marteau TM, Katzen H, Linnenbringer EL, Barber M, Whitehouse P, Quaid K, Brown T, Green RC, Relkin NR. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease Genetics in Medicine. 7: 48-53. PMID 15654228 DOI: 10.1097/01.Gim.0000151157.13716.6C |
0.367 |
|
| 2005 |
Green RC, Roberts S, Cupples A, Zick C, Whitehouse P, Relkin N. The reveal study: The impact of genetic risk assessment with APOE disclosure for Alzheimer’s disease Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.352 |
0.307 |
|
| 2005 |
Whitehouse PJ. Alzheimer: The life of a physician and the career of a disease Journal of the History of the Behavioral Sciences. 41: 406-408. DOI: 10.1002/Jhbs.20098 |
0.397 |
|
| 2004 |
Roberts JS, Barber M, Brown TM, Cupples LA, Farrer LA, LaRusse SA, Post SG, Quaid KA, Ravdin LD, Relkin NR, Sadovnick AD, Whitehouse PJ, Woodard JL, Green RC. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 6: 197-203. PMID 15266207 DOI: 10.1097/01.Gim.0000132688.55591.77 |
0.356 |
|
| 2004 |
Lee JH, Friedland R, Whitehouse PJ, Woo JI. Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 192-8. PMID 15260371 DOI: 10.1176/Appi.Neuropsych.16.2.192 |
0.367 |
|
| 2004 |
Whitehouse PJ, Frisoni GB, Post S. Breaking the diagnosis of dementia. Lancet Neurology. 3: 124-128. PMID 14747005 DOI: 10.1016/S1474-4422(03)00666-5 |
0.329 |
|
| 2004 |
Whitehouse PJ. Paying attention to acetylcholine: the key to wisdom and quality of life? Progress in Brain Research. 145: 311-7. PMID 14650925 DOI: 10.1016/S0079-6123(03)45022-X |
0.349 |
|
| 2004 |
Whitehouse PJ. Book Review Ethical Foundations of Palliative Care for Alzheimer Disease Edited by Ruth B. Purtilo and Henk A.M.J. ten Have. 368 pp. Baltimore, Johns Hopkins University Press, 2004. $49.95. 0-8018-7870-5 New England Journal of Medicine. 351: 2885-2885. DOI: 10.1056/Nejm200412303512726 |
0.331 |
|
| 2004 |
Karlawish J, Lu M, Logsdon R, Whitehouse P, Aisen P. P2-321 How much do 12 month changes in cognition and function influence changes in mild to moderate AD patients and caregivers ratings of patient quality of life? Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81065-0 |
0.307 |
|
| 2003 |
Whitehouse PJ. MSJAMA: Lessons and responses in Alzheimer disease research. Jama. 290: 115. PMID 12837723 DOI: 10.1001/Jama.290.1.115 |
0.391 |
|
| 2003 |
Whitehouse PJ. Research advances in the neurology of dementia. Alzheimer Disease and Associated Disorders. 17: 127-8. PMID 12794391 DOI: 10.1097/00002093-200304000-00012 |
0.327 |
|
| 2003 |
Roberts JS, LaRusse SA, Katzen H, Whitehouse PJ, Barber M, Post SG, Relkin N, Quaid K, Pietrzak RH, Cupples LA, Farrer LA, Brown T, Green RC. Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer Disease and Associated Disorders. 17: 86-93. PMID 12794385 DOI: 10.1097/00002093-200304000-00006 |
0.342 |
|
| 2003 |
Whitehouse PJ. Classification of the dementias. Lancet. 361: 1227. PMID 12686069 DOI: 10.1016/S0140-6736(03)12937-6 |
0.406 |
|
| 2003 |
Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. The Cochrane Database of Systematic Reviews. CD003119. PMID 12535455 DOI: 10.1002/14651858.Cd003119 |
0.393 |
|
| 2002 |
Barber M, Whitehouse PJ. Susceptibility testing for Alzheimer's disease: race for the future. The Lancet. Neurology. 1: 10. PMID 12849539 DOI: 10.1016/S1474-4422(02)00009-1 |
0.434 |
|
| 2002 |
Karlawish JHT, Knopman D, Clark CM, Morris JC, Marson D, Whitehouse PJ, Kawas CH. Informed Consent for Alzheimer's Disease Clinical Trials: A Survey of Clinical Investigators Irb: Ethics and Human Research. 24: 1. DOI: 10.2307/3563802 |
0.324 |
|
| 2002 |
Smyth KA, Neundorfer MM, Koss E, Geldmacher DS, Ogrocki PK, Whitehouse PJ. Quality of Life and Deficit Identification in Dementia Dementia. 1: 345-358. DOI: 10.1177/147130120200100306 |
0.329 |
|
| 2001 |
Whitehouse PJ. The end of Alzheimer disease II: commentary on "Decisions to treat or not to treat pneumonia in demented psychogeriatric nursing home patients". Alzheimer Disease and Associated Disorders. 15: 118. PMID 11522928 DOI: 10.1097/00002093-200107000-00002 |
0.304 |
|
| 2001 |
Mack JL, Whitehouse PJ. Quality of Life in Dementia: state of the art--report of the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society satellite meeting. Alzheimer Disease and Associated Disorders. 15: 69-71. PMID 11403334 DOI: 10.1097/00002093-200104000-00005 |
0.35 |
|
| 2001 |
Whitehouse PJ. The end of Alzheimer disease. Alzheimer Disease and Associated Disorders. 15: 59-62. PMID 11403331 DOI: 10.1097/00002093-200104000-00001 |
0.463 |
|
| 2001 |
Post SG, Stuckey JC, Whitehouse PJ, Ollerton S, Durkin C, Robbins D, Fallcreek SJ. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Disease and Associated Disorders. 15: 80-8. PMID 11391089 DOI: 10.1097/00002093-200104000-00007 |
0.393 |
|
| 2001 |
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 1154-66. PMID 11342679 DOI: 10.1212/Wnl.56.9.1154 |
0.325 |
|
| 2000 |
Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 55: 1271-8. PMID 11087767 DOI: 10.1212/Wnl.55.9.1271 |
0.316 |
|
| 2000 |
Jönsson L, Jönsson B, Wimo A, Whitehouse PJ, Winblad B. Second International Pharmacoeconomic Conference on Alzheimer's disease Alzheimer Disease & Associated Disorders. 14: 137-140. PMID 10994654 DOI: 10.1097/00002093-200007000-00004 |
0.389 |
|
| 1999 |
Whitehouse PJ. Alzheimer's disease: past, present, and future. European Archives of Psychiatry and Clinical Neuroscience. 249: 43-5. PMID 10654099 DOI: 10.1007/Pl00014173 |
0.414 |
|
| 1999 |
Jobst KA, Shostak D, Whitehouse PJ. Diseases of meaning, manifestations of health, and metaphor. Journal of Alternative and Complementary Medicine (New York, N.Y.). 5: 495-502. PMID 10630342 DOI: 10.1089/Acm.1999.5.495 |
0.372 |
|
| 1999 |
Hinze SW, Gaines AD, Lerner AJ, Whitehouse PJ. An interdisciplinary response to the Reagan Research Institute Report on Women and Alzheimer's Disease. Alzheimer Disease and Associated Disorders. 13: 183-6. PMID 10609665 DOI: 10.1097/00002093-199910000-00001 |
0.368 |
|
| 1999 |
Ballenger JF, Nelson JL, Whitehouse PJ. Beyond "progress" in the history of Alzheimer disease. Alzheimer Disease and Associated Disorders. 13: 130-1. PMID 10485570 DOI: 10.1097/00002093-199907000-00003 |
0.465 |
|
| 1999 |
Kawas CH, Clark CM, Farlow MR, Knopman DS, Marson D, Morris JC, Thal LJ, Whitehouse PJ. Clinical trials in Alzheimer disease: debate on the use of placebo controls. Alzheimer Disease and Associated Disorders. 13: 124-9. PMID 10485569 DOI: 10.1097/00002093-199907000-00002 |
0.393 |
|
| 1999 |
Whitehouse PJ, Arizaga R, Brodaty H, Gauthier S, Graham N, Green RC, Homma A, Mangone C, Senanarong V, Xu XH. Placebos in clinical trials in Alzheimer disease: an international discussion. Alzheimer Disease and Associated Disorders. 13: 121-3. PMID 10485568 DOI: 10.1097/00002093-199907000-00001 |
0.373 |
|
| 1999 |
Post SG, Whitehouse PJ. Spirituality, religion, and Alzheimer's disease. Journal of Health Care Chaplaincy. 8: 45-57. PMID 10387591 DOI: 10.1300/J080V08N01_04 |
0.42 |
|
| 1999 |
Brodaty H, Dresser R, Eisner M, Erkunjuntti T, Gauthier S, Graham N, Jonker C, Sachs G, Whitehouse PJ. Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia Alzheimer Disease and Associated Disorders. 13: 71-79. PMID 10372949 DOI: 10.1097/00002093-199904000-00003 |
0.419 |
|
| 1999 |
Cohen CA, Whitehouse PJ, Post SG, Gauthier S, Eberhart A, LeDuc L. Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force. Alzheimer Disease and Associated Disorders. 13: 66-70. PMID 10372948 DOI: 10.1097/00002093-199904000-00002 |
0.419 |
|
| 1999 |
Post SG, Whitehouse PJ, Nelson JL, Sachs GA. Alzheimer disease ethics: a continuing area of public interest. Alzheimer Disease and Associated Disorders. 13: 63-5. PMID 10372947 DOI: 10.1097/00002093-199904000-00001 |
0.422 |
|
| 1999 |
Whitehouse PJ. Cholinesterase Inhibitors in Alzheimer??s Disease Cns Drugs. 11: 167-173. DOI: 10.2165/00023210-199911030-00001 |
0.332 |
|
| 1998 |
Whitehouse PJ. Donepezil. Drugs of Today (Barcelona, Spain : 1998). 34: 321-6. PMID 15010720 |
0.358 |
|
| 1998 |
Whitehouse PJ, Kittner B, Roessner M, Rossor M, Sano M, Thal L, Winblad B. Clinical trial designs for demonstrating disease-course-altering effects in dementia. Alzheimer Disease and Associated Disorders. 12: 281-94. PMID 9876956 DOI: 10.1097/00002093-199812000-00007 |
0.454 |
|
| 1998 |
Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, Xu XH. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 12: 263-5. PMID 9876954 DOI: 10.1097/00002093-199812000-00005 |
0.39 |
|
| 1998 |
Harvey RJ, Whitehouse PJ, Rossor MN. Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997. Alzheimer Disease and Associated Disorders. 12: 259-61. PMID 9876953 DOI: 10.1097/00002093-199812000-00003 |
0.406 |
|
| 1998 |
Weiner MF, Koss E, Patterson M, Jin S, Teri L, Thomas R, Thal LJ, Whitehouse P. A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease. Journal of Psychiatric Research. 32: 347-51. PMID 9844950 DOI: 10.1016/S0022-3956(98)00027-2 |
0.351 |
|
| 1998 |
Karlawish JH, Whitehouse PJ. Is the placebo control obsolete in a world after donepezil and vitamin E? Archives of Neurology. 55: 1420-4. PMID 9823825 DOI: 10.1001/Archneur.55.11.1420 |
0.313 |
|
| 1998 |
Whitehouse PJ. The cholinergic deficit in Alzheimer's disease. The Journal of Clinical Psychiatry. 59: 19-22. PMID 9771826 |
0.332 |
|
| 1998 |
Post SG, Whitehouse PJ. Emerging antidementia drugs: a preliminary ethical view. Journal of the American Geriatrics Society. 46: 784-7. PMID 9625200 DOI: 10.1111/J.1532-5415.1998.Tb03819.X |
0.356 |
|
| 1998 |
Smith AL, Whitehouse PJ. Progress in the management of Alzheimer's disease. Hospital Practice (1995). 33: 151-4, 157-66. PMID 9522840 DOI: 10.1080/21548331.1998.11443660 |
0.453 |
|
| 1998 |
Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Research. 780: 260-9. PMID 9507158 DOI: 10.1016/S0006-8993(97)01202-X |
0.46 |
|
| 1998 |
Whitehouse PJ. An update on international harmonization concerning drug development in Alzheimer disease in memory of Professor Luigi Amaducci Alzheimer Disease and Associated Disorders. 12: 255-256. DOI: 10.1097/00002093-199812000-00001 |
0.344 |
|
| 1998 |
Koss E, Patterson MB, Mack JL, Smyth KA, Whitehouse PJ. Reliability and validity of the Tinkertoy test in evaluating individuals with Alzheimer's disease Clinical Neuropsychologist. 12: 325-329. DOI: 10.1076/Clin.12.3.325.1987 |
0.347 |
|
| 1997 |
Geldmacher DS, Lerner AJ, Voci JM, Noelker EA, Somple LC, Whitehouse PJ. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs. Journal of Geriatric Psychiatry and Neurology. 10: 99-104. PMID 9322131 DOI: 10.1177/089198879701000302 |
0.317 |
|
| 1997 |
Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, Schafer K, Sano M, Thal LJ, Thomas R, Whitehouse PJ. Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S45-50. PMID 9236952 DOI: 10.1097/00002093-199700112-00007 |
0.317 |
|
| 1997 |
Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S1-12. PMID 9236947 |
0.306 |
|
| 1997 |
Whitehouse PJ, Reidenbach F. Guidelines for early identification of Alzheimer Disease. Alzheimer Disease and Associated Disorders. 11: 61-2. PMID 9194951 |
0.326 |
|
| 1997 |
Whitehouse PJ. Genesis of Alzheimer's disease. Neurology. 48: S2-7. PMID 9153160 DOI: 10.1212/Wnl.48.5_Suppl_7.2S |
0.451 |
|
| 1997 |
Geldmacher DS, Whitehouse PJ. Differential diagnosis of Alzheimer's disease. Neurology. 48: S2-9. PMID 9153154 DOI: 10.1212/Wnl.48.5_Suppl_6.2S |
0.438 |
|
| 1997 |
Patterson MB, Mack JL, Mackell JA, Thomas R, Tariot P, Weiner M, Whitehouse PJ. A Longitudinal Study of Behavioral Pathology Across Five Levels of Dementia Severity in Alzheimerʼs Disease Alzheimer Disease & Associated Disorders. 11: 40-44. DOI: 10.1097/00002093-199700112-00006 |
0.389 |
|
| 1997 |
Whitehouse P. The international working group for harmonization of dementia drug guidelines: A progress report Biological Psychiatry. 42: 125S. DOI: 10.1016/S0006-3223(97)87418-5 |
0.343 |
|
| 1996 |
Weiner MF, Koss E, Wild KV, Folks DG, Tariot P, Luszczynska H, Whitehouse P. Measures of psychiatric symptoms in Alzheimer patients: A review Alzheimer Disease and Associated Disorders. 10: 20-30. PMID 8919493 DOI: 10.1097/00002093-199601010-00005 |
0.3 |
|
| 1996 |
Whitehouse PJ, Morris JC. Disclosure of financial interest: a new policy for Alzheimer disease and associated disorders. Alzheimer Disease and Associated Disorders. 10: 1-2. PMID 8919489 DOI: 10.1097/00002093-199601010-00001 |
0.358 |
|
| 1996 |
Whitehouse PJ. Future prospects for Alzheimer's disease therapy: ethical and policy issues for the international community. Acta Neurologica Scandinavica. Supplementum. 165: 145-9. PMID 8741002 DOI: 10.1111/J.1600-0404.1996.Tb05885.X |
0.416 |
|
| 1996 |
Geldmacher DS, Whitehouse PJ. Evaluation of dementia. The New England Journal of Medicine. 335: 330-6. PMID 8663868 DOI: 10.1056/Nejm199608013350507 |
0.345 |
|
| 1996 |
Patterson MB, Mack JL, Geldmacher DS, Whitehouse PJ. Executive functions and Alzheimer's disease: Problems and prospects European Journal of Neurology. 3: 5-15. DOI: 10.1111/J.1468-1331.1996.Tb00182.X |
0.411 |
|
| 1996 |
Ferris SH, Khachaturian Z, Lebowitz B, Oderda G, Radebaugh T, Teresi J, Whitehouse P. Round Table Discussion: The Scientist's View on Outcome Methodologies for Pharmacologic Trials in Mild, Moderate, and Severe Alzheimer's Disease International Psychogeriatrics. 8: 343-344. DOI: 10.1017/S1041610296002700 |
0.378 |
|
| 1996 |
Friedland R, Smyth K, Esteban-Santillan C, Koss E, Cole R, Lemer A, Strauss M, Whitehouse P, Petot G, Rowland D, Debanne S. 490 Premorbid environmental complexity is reduced in patients with Alzheimer's disease (AD) as compared to age and sex matched controls: Results of a Case-Control Study Neurobiology of Aging. 17: S122. DOI: 10.1016/S0197-4580(96)80492-1 |
0.408 |
|
| 1996 |
Whitehouse PJ, Smyth KA, Neundorfer MM, Stuckey JC. 335 Industry roundtable “Slowing the progression of Alzheimer's disease: Methodology and ethical issues” pharmacoeconomics Neurobiology of Aging. 17: S84. DOI: 10.1016/S0197-4580(96)80337-X |
0.44 |
|
| 1995 |
Shimohama S, Fujimoto S, Chachin M, Taniguchi T, Perry G, Whitehouse PJ, Kimura J. Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease. Brain Research. 699: 125-9. PMID 8616601 DOI: 10.1016/0006-8993(95)00995-3 |
0.47 |
|
| 1995 |
Whitehouse PJ, Kalaria RN. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Disease and Associated Disorders. 9: 3-5. PMID 8534421 DOI: 10.1097/00002093-199501002-00002 |
0.44 |
|
| 1995 |
Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. Gender differences in language of AD patients: a longitudinal study. Neurology. 45: 299-302. PMID 7854529 DOI: 10.1212/Wnl.45.2.299 |
0.311 |
|
| 1995 |
Shimohama S, Fujimoto S, Matsushima H, Takenawa T, Taniguchi T, Perry G, Whitehouse PJ, Kimura J. Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease. Journal of Neurochemistry. 64: 2629-34. PMID 7760043 DOI: 10.1046/J.1471-4159.1995.64062629.X |
0.516 |
|
| 1995 |
Shimohama S, Perry G, Richey P, Praprotnik D, Takenawa T, Fukami K, Whitehouse PJ, Kimura J. Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles. Brain Research. 669: 217-24. PMID 7712177 DOI: 10.1016/0006-8993(94)01239-E |
0.461 |
|
| 1995 |
Whitehouse PJ, Deal WE. Situated beyond modernity: lessons for Alzheimer's disease research. Journal of the American Geriatrics Society. 43: 1314-5. PMID 7594171 DOI: 10.1111/J.1532-5415.1995.Tb07413.X |
0.442 |
|
| 1995 |
Whitehouse PJ, Voci J. Therapeutic trials in Alzheimer's disease. Current Opinion in Neurology. 8: 275-8. PMID 7582042 DOI: 10.1097/00019052-199508000-00005 |
0.411 |
|
| 1995 |
Whitehouse PJ. Should we differentiate subtypes of Alzheimer disease? Alzheimer Disease and Associated Disorders. 9: S1. PMID 7546593 |
0.336 |
|
| 1995 |
Post SG, Whitehouse PJ. Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer's Association. Journal of the American Geriatrics Society. 43: 1423-9. PMID 7490397 DOI: 10.1111/J.1532-5415.1995.Tb06625.X |
0.428 |
|
| 1995 |
Ferris SH, Hasegawa K, Homma A, Khachaturian ZS, Post S, Rossor M, Whitehouse PJ. International efforts to improve Alzheimer disease treatment Alzheimer Disease & Associated Disorders. 9: 181. DOI: 10.1097/00002093-199500940-00001 |
0.412 |
|
| 1994 |
Post SG, Ripich DN, Whitehouse PJ. Discourse ethics: research, dementia, and communication. Alzheimer Disease and Associated Disorders. 8: 58-65. PMID 11657675 DOI: 10.1097/00002093-199400000-00007 |
0.354 |
|
| 1994 |
Lerner AJ, Koss E, Patterson MB, Ownby RL, Hedera P, Friedland RP, Whitehouse PJ. Concomitants of visual hallucinations in Alzheimer's disease. Neurology. 44: 523-7. PMID 8145925 DOI: 10.1212/Wnl.44.3_Part_1.523 |
0.385 |
|
| 1994 |
Whitehouse PJ, Geldmacher DS. Pharmacotherapy for Alzheimer's disease. Clinics in Geriatric Medicine. 10: 339-50. PMID 8039102 |
0.311 |
|
| 1994 |
Lanska DJ, Currier RD, Cohen M, Gambetti P, Smith EE, Bebin J, Jackson JF, Whitehouse PJ, Markesbery WR. Familial progressive subcortical gliosis. Neurology. 44: 1633-43. PMID 7936288 DOI: 10.1212/Wnl.44.9.1633 |
0.365 |
|
| 1994 |
Ownby RL, Koss E, Smyth KA, Whitehouse PJ. The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 7: 245-50. PMID 7826495 DOI: 10.1177/089198879400700410 |
0.357 |
|
| 1994 |
Whitehouse PJ, Geldmacher DS. Pharmacotherapy for Alzheimer’s Disease Clinics in Geriatric Medicine. 10: 339-350. DOI: 10.1016/S0749-0690(18)30349-5 |
0.394 |
|
| 1994 |
Whitehouse PJ. Alzheimer's disease: Treatments on the horizon P and T. 19: 153-155+159-160+164-. |
0.327 |
|
| 1993 |
Koss E, Patterson MB, Ownby R, Stuckey JC, Whitehouse PJ. Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing. Archives of Neurology. 50: 92-7. PMID 8418807 DOI: 10.1001/Archneur.1993.00540010086023 |
0.377 |
|
| 1993 |
Mack JL, Patterson MB, Schnell AH, Whitehouse PJ. Performance of subjects with probable Alzheimer disease and normal elderly controls on the Gollin Incomplete Pictures Test. Perceptual and Motor Skills. 77: 951-69. PMID 8284183 DOI: 10.2466/Pms.1993.77.3.951 |
0.308 |
|
| 1993 |
Shimohama S, Fujimoto S, Tresser N, Richey P, Perry G, Whitehouse PJ, Homma Y, Takenawa T, Taniguchi T, Suenaga T. Aberrant phosphoinositide metabolism in Alzheimer's disease. Annals of the New York Academy of Sciences. 695: 46-9. PMID 8239311 DOI: 10.1111/J.1749-6632.1993.Tb23025.X |
0.533 |
|
| 1993 |
Whitehouse PJ, Landreth G, Younkin S. Molecular biology of Alzheimer's disease. Molecular Genetic Medicine. 3: 95-137. PMID 8220165 DOI: 10.1016/B978-0-12-462003-2.50008-0 |
0.442 |
|
| 1993 |
Whitehouse PJ. Cholinergic therapy in dementia. Acta Neurologica Scandinavica. Supplementum. 149: 42-5. PMID 8128838 DOI: 10.1111/J.1600-0404.1993.Tb04254.X |
0.409 |
|
| 1993 |
Shimohama S, Perry G, Richey P, Takenawa T, Whitehouse PJ, Miyoshi K, Suenaga T, Matsumoto S, Nishimura M, Kimura J. Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases. Neuroscience Letters. 162: 183-6. PMID 8121625 DOI: 10.1016/0304-3940(93)90591-8 |
0.553 |
|
| 1992 |
Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ. Disturbances of person identification in Alzheimer's disease. A retrospective study. The Journal of Nervous and Mental Disease. 180: 94-6. PMID 1737981 DOI: 10.1097/00005053-199202000-00005 |
0.352 |
|
| 1992 |
Chatterjee A, Strauss ME, Smyth KA, Whitehouse PJ. Personality changes in Alzheimer's disease. Archives of Neurology. 49: 486-91. PMID 1580810 DOI: 10.1001/Archneur.1992.00530290070014 |
0.415 |
|
| 1992 |
Patterson MB, Mack JL, Neundorfer MM, Martin RJ, Smyth KA, Whitehouse PJ. Assessment of functional ability in Alzheimer disease: a review and a preliminary report on the Cleveland Scale for Activities of Daily Living. Alzheimer Disease and Associated Disorders. 6: 145-63. PMID 1485930 DOI: 10.1097/00002093-199206030-00003 |
0.348 |
|
| 1992 |
Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. The New England Journal of Medicine. 327: 1253-9. PMID 1406817 DOI: 10.1056/Nejm199210293271801 |
0.3 |
|
| 1992 |
Patterson MB, Whitehouse PJ. Behavioral symptoms in Alzheimer disease: a look ahead. Alzheimer Disease and Associated Disorders. 6: 71-2. PMID 1389081 DOI: 10.1097/00002093-199206020-00001 |
0.362 |
|
| 1992 |
Whitehouse PJ. Alzheimer's disease: relationship of cognition and behavior to neurochemistry. International Psychogeriatrics / Ipa. 4: 71-8. PMID 1354507 DOI: 10.1017/S1041610292001169 |
0.393 |
|
| 1992 |
Post SG, Whitehouse PJ. Alzheimer Disease and Associated Disorders Alzheimer Disease & Associated Disorders. 6: 1-2. DOI: 10.1097/00002093-199205000-00001 |
0.394 |
|
| 1991 |
Whitehouse PJ. Pathology in the cholinergic basal forebrain: implications for treatment. Advances in Experimental Medicine and Biology. 295: 447-52. PMID 1776582 DOI: 10.1007/978-1-4757-0145-6_26 |
0.316 |
|
| 1991 |
Whitehouse PJ. Treatment of Alzheimer disease. Alzheimer Disease and Associated Disorders. 5: S32-6. PMID 1685885 DOI: 10.1097/00002093-199100051-00006 |
0.363 |
|
| 1991 |
Whitehouse PJ. Intramuscular desferrioxamine slowed the decline in living skills in Alzheimer disease Acp Journal Club. 115: 41-41. DOI: 10.7326/Acpjc-1991-115-2-041 |
0.414 |
|
| 1991 |
Namazi KH, Whitehouse PJ, Rechlin LR, Calkins MP, Johnson BD, Brabender BA, Hevener SM. Environmental modifications in a specially designed unit for the care of patients with Alzheimer's disease: An overview and introduction American Journal of Alzheimer's Care and Related Disorders & Research. 6: 3-9. DOI: 10.1177/153331759100600602 |
0.373 |
|
| 1991 |
Chatterjee A, Mack J, Whitehouse PJ. Dementia: Nosology and Brain-Behavior Relationships Dementia and Geriatric Cognitive Disorders. 2: 116-120. DOI: 10.1159/000107186 |
0.39 |
|
| 1990 |
Wagster MV, Whitehouse PJ, Walker LC, Kellar KJ, Price DL. Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2879-85. PMID 2398366 DOI: 10.1523/Jneurosci.10-09-02879.1990 |
0.328 |
|
| 1990 |
Patterson MB, Schnell AH, Martin RJ, Mendez MF, Smyth KA, Whitehouse PJ. Assessment of behavioral and affective symptoms in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 3: 21-30. PMID 2346584 DOI: 10.1177/089198879000300106 |
0.364 |
|
| 1990 |
Mendez MF, Mendez MA, Martin R, Smyth KA, Whitehouse PJ. Complex visual disturbances in Alzheimer's disease. Neurology. 40: 439-43. PMID 2314585 DOI: 10.1212/Wnl.40.3_Part_1.439 |
0.313 |
|
| 1989 |
Whitehouse PJ. Parkinson's disease and Alzheimer's disease: new neurochemical parallels. Movement Disorders : Official Journal of the Movement Disorder Society. 4: S57-62. PMID 2786144 DOI: 10.1002/Mds.870040508 |
0.44 |
|
| 1989 |
Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL. Neuropathology of aminergic nuclei in Alzheimer's disease. Progress in Clinical and Biological Research. 317: 353-65. PMID 2602423 |
0.462 |
|
| 1989 |
Whitehouse PJ, Gambetti P, Harik SI, Kalaria RN, Perry G, Younkin SI, Tabaton M, Unnerstall JR. Neurochemistry of dementia: establishing the links. Progress in Clinical and Biological Research. 317: 131-42. PMID 2574868 |
0.348 |
|
| 1989 |
McConnell DW, Whitehouse PJ. Clinical Management of Alzheimer's Disease Neurology. 39: 158-158. DOI: 10.1212/Wnl.39.1.158-A |
0.404 |
|
| 1989 |
Whitehouse PJ. Alzheimer's Disease: A Psychiatrically Treatable Condition? The Gerontologist. 29: 423-425. DOI: 10.1093/Geront/29.3.423 |
0.442 |
|
| 1988 |
Smyth K, Whitehouse PJ, Rust M, Kahana J. Epidemiology, diagnosis, and management of Alzheimer's disease and related disorders: implications for minority populations. Health Matrix. 6: 28-32. PMID 10318201 |
0.304 |
|
| 1988 |
Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ. Reductions in acetylcholine and nicotine binding in several degenerative diseases. Archives of Neurology. 45: 722-4. PMID 3390025 DOI: 10.1001/archneur.1988.00520310028012 |
0.459 |
|
| 1988 |
Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38: 720-3. PMID 3362368 DOI: 10.1212/Wnl.38.5.720 |
0.544 |
|
| 1988 |
Zweig RM, Hedreen JC, Jankel WR, Casanova MF, Whitehouse PJ, Price DL. Pathology in brainstem regions of individuals with primary dystonia. Neurology. 38: 702-6. PMID 3362365 DOI: 10.1212/Wnl.38.5.702 |
0.583 |
|
| 1988 |
Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL. The neuropathology of aminergic nuclei in Alzheimer's disease. Annals of Neurology. 24: 233-42. PMID 3178178 DOI: 10.1002/Ana.410240210 |
0.547 |
|
| 1988 |
Tabaton M, Whitehouse PJ, Perry G, Davies P, Autilio-Gambetti L, Gambetti P. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Annals of Neurology. 24: 407-13. PMID 3067653 DOI: 10.1002/Ana.410240309 |
0.52 |
|
| 1988 |
Casanova MF, Struble RG, Whitehouse PJ, Price DL. A historical perspective on the neuropathology of dementia with emphasis on the senile plaque. BoletãN De La Asociaciã³N Mã©Dica De Puerto Rico. 80: 424-8. PMID 3064761 |
0.736 |
|
| 1988 |
Hedreen JC, Zweig RM, DeLong MR, Whitehouse PJ, Price DL. Primary dystonias: a review of the pathology and suggestions for new directions of study. Advances in Neurology. 50: 123-32. PMID 3041757 |
0.341 |
|
| 1988 |
Whitehouse PJ, Unnerstall JR. Neurochemistry of dementia. European Neurology. 28: 36-41. PMID 2967756 |
0.33 |
|
| 1988 |
Whitehouse PJ. Intraventricular bethanechol in Alzheimer's disease: a continuing controversy. Neurology. 38: 307-8. PMID 2893315 DOI: 10.1212/Wnl.38.2.307 |
0.471 |
|
| 1988 |
Whitehouse PJ. Benzodiazepine receptors in Huntington's disease Neurology. 38: 509-509. DOI: 10.1212/Wnl.38.3.509-B |
0.36 |
|
| 1988 |
ZWEIG RM, ROSS CA, HEDREEN JC, STEELE C, CARDILLO JE, WHITEHOUSE PJ, FOLSTEIN MF, PRICE DL. THE NEUROPATHOLOGY OF AMINERGIC NUCLEI IN ALZHEIMER??S DISEASE Alzheimer Disease & Associated Disorders. 2: 231. DOI: 10.1097/00002093-198802030-00080 |
0.602 |
|
| 1987 |
Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Research. 436: 62-8. PMID 3690354 DOI: 10.1016/0006-8993(87)91556-3 |
0.52 |
|
| 1987 |
Zweig RM, Whitehouse PJ, Casanova MF, Walker LC, Jankel WR, Price DL. Loss of pedunculopontine neurons in progressive supranuclear palsy. Annals of Neurology. 22: 18-25. PMID 3631916 DOI: 10.1002/Ana.410220107 |
0.65 |
|
| 1987 |
Wand GS, May C, May V, Whitehouse PJ, Rapoport SI, Eipper BA. Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF. Neurology. 37: 1057-61. PMID 3587629 DOI: 10.1212/Wnl.37.6.1057 |
0.37 |
|
| 1987 |
Price DL, Cork LC, Struble RG, Kitt CA, Walker LC, Powers RE, Whitehouse PJ, Griffin JW. Dysfunction and death of neurons in human degenerative neurological diseases and in animal models. Ciba Foundation Symposium. 126: 30-48. PMID 3556088 |
0.688 |
|
| 1987 |
Powers RE, Walker LC, DeSouza EB, Vale WW, Struble RG, Whitehouse PJ, Price DL. Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease. Synapse (New York, N.Y.). 1: 405-10. PMID 3509803 DOI: 10.1002/Syn.890010504 |
0.725 |
|
| 1987 |
De Souza EB, Whitehouse PJ, Price DL, Vale WW. Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Annals of the New York Academy of Sciences. 512: 237-47. PMID 3502064 DOI: 10.1111/J.1749-6632.1987.Tb24964.X |
0.545 |
|
| 1987 |
Whitehouse PJ, Vale WW, Zweig RM, Singer HS, Mayeux R, Kuhar MJ, Price DL, De Souza EB. Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology. 37: 905-9. PMID 3495748 DOI: 10.1212/Wnl.37.6.905 |
0.573 |
|
| 1987 |
D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH. Aminergic systems in Alzheimer's disease and Parkinson's disease. Annals of Neurology. 22: 229-36. PMID 3477996 DOI: 10.1002/Ana.410220207 |
0.583 |
|
| 1987 |
Whitehouse PJ, Kellar KJ. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders. Journal of Neural Transmission. Supplementum. 24: 175-82. PMID 2960781 |
0.339 |
|
| 1987 |
De Souza EB, Whitehouse PJ, Folstein SE, Price DL, Vale WW. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease. Brain Research. 437: 355-9. PMID 2893655 DOI: 10.1016/0006-8993(87)91651-9 |
0.548 |
|
| 1987 |
Unnerstall JR, Whitehouse PJ. New approaches to quantitative neuropathology: multivariate analysis of morphologic and neurochemical measures. Neurobiology of Aging. 8: 567-9. PMID 2893305 DOI: 10.1016/0197-4580(87)90138-2 |
0.319 |
|
| 1987 |
Whitehouse PJ. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. Advances in Neurology. 45: 393-7. PMID 2881448 |
0.349 |
|
| 1987 |
Whitehouse PJ. Neurotransmitter receptor alterations in Alzheimer disease: a review. Alzheimer Disease and Associated Disorders. 1: 9-18. PMID 2840100 DOI: 10.1097/00002093-198701000-00003 |
0.432 |
|
| 1987 |
Whitehouse PJ. ???THE ROLE OF THE NUCLEUS BASALIS OF MEYNERT IN DEMENTIA: REVIEW AND RECONSIDERATION??? Alzheimer Disease & Associated Disorders. 1: 149-151. DOI: 10.1097/00002093-198701030-00005 |
0.324 |
|
| 1986 |
Clark AW, White CL, Manz HJ, Parhad IM, Curry B, Whitehouse PJ, Lehmann J, Coyle JT. Primary degenerative dementia without Alzheimer pathology. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 462-70. PMID 3791063 DOI: 10.1017/S0317167100037136 |
0.426 |
|
| 1986 |
Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Research. 371: 146-51. PMID 3708340 DOI: 10.1016/0006-8993(86)90819-X |
0.529 |
|
| 1986 |
Whitehouse PJ, Au KS. Cholinergic receptors in aging and Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 665-76. PMID 3541056 |
0.315 |
|
| 1986 |
Price DL, Struble RG, Whitehouse PJ, Kitt CA, Cork LC, Walker LC, Casanova MF. Alzheimer's disease: a multisystem disorder. Research Publications - Association For Research in Nervous and Mental Disease. 64: 209-14. PMID 3523660 |
0.745 |
|
| 1986 |
Uhl GR, Hackney GO, Torchia M, Stranov V, Tourtellotte WW, Whitehouse PJ, Tran V, Strittmatter S. Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation. Annals of Neurology. 20: 194-203. PMID 3019228 DOI: 10.1002/Ana.410200204 |
0.303 |
|
| 1986 |
De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature. 319: 593-5. PMID 3003585 DOI: 10.1038/319593A0 |
0.562 |
|
| 1986 |
Whitehouse PJ. Understanding the etiology of Alzheimer's disease. Current approaches. Neurologic Clinics. 4: 427-37. PMID 2940457 |
0.315 |
|
| 1986 |
Whitehouse PJ, Unnerstall JR. The continuing search for the primary event in alzheimer's disease: a criticism Neurobiology of Aging. 7: 517-518. DOI: 10.1016/0197-4580(86)90097-7 |
0.422 |
|
| 1986 |
Price DL, Whitehouse PJ, Struble RG. Cellular pathology in Alzheimer's and Parkinson's diseases Trends in Neurosciences. 9: 29-33. DOI: 10.1016/0166-2236(86)90011-1 |
0.697 |
|
| 1985 |
Whitehouse PJ. Theodor Meynert: foreshadowing modern concepts of neuropsychiatric pathophysiology. Neurology. 35: 389-91. PMID 3883237 DOI: 10.1212/Wnl.35.3.389 |
0.434 |
|
| 1985 |
Price DL, Cork LC, Struble RG, Whitehouse PJ, Kitt CA, Walker LC. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease. Annals of the New York Academy of Sciences. 444: 287-95. PMID 3160283 DOI: 10.1111/J.1749-6632.1985.Tb37597.X |
0.721 |
|
| 1985 |
Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Annals of Neurology. 18: 202-10. PMID 2994554 DOI: 10.1002/Ana.410180207 |
0.464 |
|
| 1985 |
Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Kuhar MJ. Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements. Annals of Neurology. 17: 518. PMID 2988415 DOI: 10.1002/ana.410170518 |
0.309 |
|
| 1985 |
Casanova MF, Walker LC, Whitehouse PJ, Price DL. Abnormalities of the nucleus basalis in Down's syndrome. Annals of Neurology. 18: 310-3. PMID 2932050 DOI: 10.1002/Ana.410180306 |
0.633 |
|
| 1985 |
Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, Price DL. Alzheimer's disease and related dementias: selective involvement of specific neuronal systems. Crc Critical Reviews in Clinical Neurobiology. 1: 319-39. PMID 2876845 |
0.724 |
|
| 1985 |
Price DL, Kitt CA, Struble RG, Whitehouse PJ, Cork LC, Walker LC. Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia. Annals of the New York Academy of Sciences. 457: 35-51. PMID 2869729 DOI: 10.1111/J.1749-6632.1985.Tb20798.X |
0.696 |
|
| 1985 |
Price DL, Whitehouse PJ, Struble RG. Alzheimer's disease. Annual Review of Medicine. 36: 349-56. PMID 2859830 DOI: 10.1146/annurev.me.36.020185.002025 |
0.714 |
|
| 1984 |
Hedreen JC, Struble RG, Whitehouse PJ, Price DL. Topography of the magnocellular basal forebrain system in human brain. Journal of Neuropathology and Experimental Neurology. 43: 1-21. PMID 6319616 DOI: 10.1097/00005072-198401000-00001 |
0.687 |
|
| 1984 |
Uhl GR, Whitehouse PJ, Price DL, Tourtelotte WW, Kuhar MJ. Parkinson's disease: depletion of substantia nigra neurotensin receptors. Brain Research. 308: 186-90. PMID 6089953 DOI: 10.1016/0006-8993(84)90935-1 |
0.479 |
|
| 1984 |
Clark AM, Manz HJ, White CL, Lehmann J, Whitehouse PJ, Coyle JT. 49 NEUROPATHOLOGICAL AND NEUROCHEMICAL FINDINGS IN ANATOMICALLY ATYPICAL CASES OF DEMENTIA Journal of Neuropathology and Experimental Neurology. 43: 309. DOI: 10.1097/00005072-198405000-00058 |
0.336 |
|
| 1984 |
Whitehouse PJ, Kitt CA, Hedreen JC, Struble RG, Kuhar MJ, Price DL. NEUROPATHOLOGICAL FINDINGS IN THE ACETYLCHOLINERGIC SYSTEM IN ALZHEIMERʼS DISEASE AND SENILE DEMENTIA OF THE ALZHEIMERʼS TYPE Clinical Neuropharmacology. 7: S11. DOI: 10.1097/00002826-198406001-00013 |
0.702 |
|
| 1983 |
Whitehouse PJ, Hedreen JC, White CL, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Annals of Neurology. 13: 243-8. PMID 6847136 DOI: 10.1002/Ana.410130304 |
0.594 |
|
| 1983 |
Uhl GR, Hilt DC, Hedreen JC, Whitehouse PJ, Price DL. Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology. 33: 1470-3. PMID 6685239 DOI: 10.1212/Wnl.33.11.1470 |
0.56 |
|
| 1983 |
Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. Psychopharmacology Bulletin. 19: 437-40. PMID 6635120 |
0.72 |
|
| 1983 |
Clark AW, Parhad IM, Folstein SE, Whitehouse PJ, Hedreen JC, Price DL, Chase GA. The nucleus basalis in Huntington's disease. Neurology. 33: 1262-7. PMID 6225032 DOI: 10.1212/Wnl.33.10.1262 |
0.59 |
|
| 1983 |
Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Tourtellotte WW, Kuhar MJ. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors. Annals of Neurology. 14: 8-16. PMID 6137185 DOI: 10.1002/Ana.410140103 |
0.455 |
|
| 1983 |
Clark AW, Lehmann J, Whitehouse PJ, Struble RG, Coyle JT, Price DL. 89 CORTICO-STRIATO-SPINAL DEGENERATION (CSSD) MIMICKING ALZHEIMERʼS DISEASE (AD) Journal of Neuropathology and Experimental Neurology. 42: 334. DOI: 10.1097/00005072-198305000-00096 |
0.697 |
|
| 1983 |
Troncoso JC, Whitehouse PJ, Kuhar MJ, Griffin JW, Cork LC, Price DL. 24 CHANGES OF MOTOR NEURON CHOLINERGIC RECEPTORS AFTER AXOTOMY Journal of Neuropathology and Experimental Neurology. 42: 313. DOI: 10.1097/00005072-198305000-00034 |
0.431 |
|
| 1982 |
Whitehouse PJ, Struble RG, Clark AW, Price DL. Alzheimer disease: plaques, tangles, and the basal forebrain. Annals of Neurology. 12: 494. PMID 7181455 DOI: 10.1002/Ana.410120517 |
0.723 |
|
| 1982 |
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (New York, N.Y.). 215: 1237-9. PMID 7058341 DOI: 10.1126/Science.7058341 |
0.725 |
|
| 1982 |
Struble RG, Cork LC, Whitehouse PJ, Price DL. Cholinergic innervation in neuritic plaques. Science (New York, N.Y.). 216: 413-5. PMID 6803359 DOI: 10.1126/Science.6803359 |
0.709 |
|
| 1982 |
Price DL, Whitehouse PJ, Struble RG, Coyle JT, Clark AW, Delong MR, Cork LC, Hedreen JC. Alzheimer's disease and Down's syndrome. Annals of the New York Academy of Sciences. 396: 145-64. PMID 6217772 DOI: 10.1111/J.1749-6632.1982.Tb26850.X |
0.693 |
|
| 1982 |
Hedreen JC, Struble RG, Clark AW, Whitehouse PJ, Price DL. THE SEPTAL/DIAGONAL BAND/BASAL NUCLEUS SYSTEM IN HUMAN BRAIN Journal of Neuropathology and Experimental Neurology. 41: 378. DOI: 10.1097/00005072-198205000-00121 |
0.634 |
|
| 1982 |
Struble RG, White CL, Clark AW, Whitehouse PJ, Cork LC, Price DL. ACETYLCHOLINESTERASE AND AMYLOID IN NEURITIC PLAQUES IN PRIMATE BRAIN Journal of Neuropathology and Experimental Neurology. 41: 364. DOI: 10.1097/00005072-198205000-00077 |
0.671 |
|
| 1982 |
Whitehouse PJ, Price DL, Hedreen JC, Struble RG, Criss TB, Sterner RE, Kuhar MJ. COMPUTER IMAGE ANALYSIS IN NEURODEGENERATIVE DISORDERS Journal of Neuropathology and Experimental Neurology. 41: 360. DOI: 10.1097/00005072-198205000-00066 |
0.624 |
|
| 1981 |
Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Annals of Neurology. 10: 122-6. PMID 7283399 DOI: 10.1002/Ana.410100203 |
0.565 |
|
| 1981 |
Whitehouse PJ, Clark AW, Price DL, Struble RG, g D, Coyle JT. 72 ALZHEIMERʼS DISEASE (AD) Journal of Neuropathology and Experimental Neurology. 40: 323. DOI: 10.1097/00005072-198105000-00079 |
0.724 |
|
| Show low-probability matches. |
